The study of effects of additional beraprost on the amelioration and retention of retinal and choroidal circulation after ranibizumab treatment in age-related macular degeneration.
Not Applicable
Recruiting
- Conditions
- age-related macular degeneration
- Registration Number
- JPRN-UMIN000006869
- Lead Sponsor
- agasaki university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
glaucoma,hypertension,past history or risk of stroke, bleeding, tendency of bleeding, other anticoagulant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method after 6 months from beginning of the medication
- Secondary Outcome Measures
Name Time Method